- Robin Farmanfarmaian
- Wednesday, May 10, 2023
- 12:45 – 2:15 p.m.
Robin Farmanfarmaian is a Silicon Valley based entrepreneur working in cutting edge tech poised to
impact 100M people or more. Robin has been involved with over 20 early-stage biotech and
healthcare startups, including working with small molecules found using AI for drug discovery to
cure cancer (p53 & AhR pathways).
She has also worked on medical devices including inhaled insulin and sleep apnea, and co-founded a non-profit that worked with DARPA, the DoD, and the White House to help fund scientists and create a scientific roadmap to solve cryopreservation and tissue engineering for organ transplants. She is an advisor to multiple companies, including: Luxsonic Technologies, working on a portable and modular radiology reading room in VR; Alacrity Care, remote patient monitoring and data analytics for oncology; and ConceptVines, a VC fund and product engineering firm focused on disruptive tech.
She has written 4 books, including The Patient as CEO: How Technology Empowers the Healthcare Consumer (2015) and How AI Can Democratize Healthcare: The Rise in Digital Care (2022) written with Michael Ferro, an entrepreneur with many technology patents and multiple large exits, including the 2015 sale of Merge Healthcare to IBM for $1B.